跳至主要内容
临床试验/IRCT2015011820711N1
IRCT2015011820711N1已完成3 期

Efficacy of Nasal Spray Calcitonin on Recurrence of Aggressive Central Giant Cell Granuloma

Shiraz University of Medical Sciences0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 30 years(—)
性别
All

入选标准

  • Inclusion Criteria:
  • clinical and histopathological diagnosis of aggressive CGCG based on accepted criteria established by chuong etal; normal level of calcitonin and serum Parathyroid hormone(PTH) Patients; ;of both sexes between 13 to 30 year's old Patients who gave written informed consent Patients who were willing for evaluation in the fallow up session; Primary size of the lesion should be more than 5 cm in CBCT;

排除标准

  • Participants demonstrating a systemic disease which affects bone healing;brown tumor ;pregnancy ; recently corticosteroid therapy ; previous surgical intervention for CGCG or refused study enrollment and whom they could not continue the study for private or social reasons were excluded from the study sample.

研究者

相似试验